reference/28899803

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28899803

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	132
issn	1461-7285 0269-8811
issueIdentifier	1
pageRange	125-132
publicationName	Journal of psychopharmacology (Oxford, England)
startingPage	125
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1ff8fbc853aaba81116f15fb8aa8690d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63b0170e74f5539063665f64480a5da4
bibliographicCitation	Horder J, Browning M, Di Simplicio M, Cowen PJ, Harmer CJ. Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol. 2012 Jan;26(1):125–32. doi: 10.1177/0269881111400649. PMID: 21406493.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6412f90a7bcccfa2ef25c5ae86269ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9108-3144 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5701-9659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_809a00993550367963cdb47bcfa0d8f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b142417de310a9b3b6339db417511af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e31c655eacb1e6ed0905b55383e1f46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4863-9914 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9932d52833cd0c0f35005fbdc2dcdbfe
date	2011-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1177/0269881111400649 https://pubmed.ncbi.nlm.nih.gov/21406493
isPartOf	https://portal.issn.org/resource/ISSN/1461-7285 https://portal.issn.org/resource/ISSN/0269-8811 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20554
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
discusses	http://id.nlm.nih.gov/mesh/M0235470 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0155202 http://id.nlm.nih.gov/mesh/M0016885
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D043884Q000037 http://id.nlm.nih.gov/mesh/D004644Q000187 http://id.nlm.nih.gov/mesh/D011720Q000494 http://id.nlm.nih.gov/mesh/D010880Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011720Q000009 http://id.nlm.nih.gov/mesh/D001008Q000378 http://id.nlm.nih.gov/mesh/D001008Q000139 http://id.nlm.nih.gov/mesh/D021641Q000187 http://id.nlm.nih.gov/mesh/D003863Q000139 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D010880Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077285 http://id.nlm.nih.gov/mesh/D043884Q000378 http://id.nlm.nih.gov/mesh/D003863Q000378 http://id.nlm.nih.gov/mesh/D008570Q000187 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281515

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128348432

Total number of triples: 60.